To date, more than half of extant wild felid species are threatened by extinction in their native ranges \[[@r1]\]. Thus, it is important to establish insurance populations of certain species *ex situ*, a process that can help retain the necessary genetic diversity to ensure species integrity \[[@r2]\]. Within these threatened species collections, there are many genetically valuable females that have never reproduced or have experienced fertility issues as a result of advanced age. To propagate these individuals, efforts have been focused on developing "assisted breeding" technologies originally established in livestock and humans, including *in vitro* embryo production, to ensure that genetics of all individuals are represented in *ex situ* populations \[[@r3],[@r4],[@r5]\]. Thus far, live offspring have been produced after transferring *in vitro*-derived embryos into recipient females in wild felids species \[[@r6],[@r7],[@r8]\]. Despite these successes, there are still challenges associated with the limited numbers of good quality oocytes available for *in vitro* embryo production due to old age \[[@r9]\] or poor responses to ovarian stimulation protocols \[[@r10]\].

Thus, it is necessary to culture gametes/embryos individually or in small groups \[[@r11], [@r12]\]. However, it has been shown in the mouse and cow that small percentages of embryos cultured singly develop to blastocysts when compared with those incubated in groups (mouse, 49% *vs*. \> 80%; cow, 2.9% *vs*. 30.7%) \[[@r11], [@r13]\]. Furthermore, previous studies have also demonstrated that individually cultured cat \[[@r9]\] and cow embryos \[[@r14]\] fail to reach the compaction stage. To date, several strategies have been established to overcome the poor developmental rate of singly cultured embryos \[[@r11]\]. These include growth factor supplementation, *in vitro* culture in conditioned medium derived from group-embryo culture and co-culture with autologous cumulus cells \[[@r11], [@r13], [@r15],[@r16],[@r17]\]. Various growth factors such as epidermal growth factor (EGF) and insulin-like growth factor-1 (IGF-1) have been shown to enhance blastocyst development in a single-embryo culture system in the mouse and cow \[[@r13], [@r18], [@r19]\]. For the cat, we have recently shown that IGF-1 promotes blastocyst development in a single-embryo culture system by enhancing the expression of its receptor (IGF-1R) \[[@r20]\]. Up to now, there has been no information available on the influence of EGF on the developmental competence of cat embryos either cultured in groups or individually.

Epidermal growth factor is a mitogenic polypeptide that is involved in regulating cell proliferation in many cell types, including granulosa cells of preantral follicles \[[@r21], [@r22]\]. This growth factor also has been shown to promote *in vitro* maturation (IVM) of mouse, cat, sheep and pig oocytes \[[@r23],[@r24],[@r25],[@r26],[@r27],[@r28]\]. Addition of EGF to IVM or culture medium promotes cleavage and blastocyst development \[[@r13], [@r29],[@r30],[@r31],[@r32],[@r33],[@r34]\]. EGF binds with its receptor (*EGFR*) and stimulates MAP/ERK and PI3K/Akt pathways that, in turn, enhance cell proliferation \[[@r22]\]. It has been shown that *EGFR* is expressed in the 2-cell to blastocyst stage in the mouse and from the 8-cell stage to the blastocyst stage in humans \[[@r35]\], but it is unknown whether it is expressed in cat embryos. Although the single-embryo culture method has been studied in several species, the quality of blastocysts produced from this has not been clearly identified. It has been suggested that expression of Ki67 and OCT3/4 can be used as markers for blastocyst quality. Ki67 is involved in cell proliferation and is only expressed in the active stage of a cell cycle \[[@r36], [@r37]\]. Pluripotency protein, OCT3/4, has been shown to be highly expressed within an inner cell mass of blastocyst stage embryos and is critical for embryogenesis and cell differentiation \[[@r38], [@r39]\].

The objectives of this study were to determine the effects of EGF during *in vitro* culture (IVC) on (1) developmental competence as well as expressions of pluripotency marker protein (OCT3/4) and proliferation marker protein (Ki67) and (2) the *EGFR* expression at various developmental stages of cat embryos cultured in a group versus singly. The research hypotheses were (1) that supplementation of a culture environment with EGF would promote embryonic development by stimulating cell proliferation and (2) that *EGFR* is expressed in cat preimplantation embryos.

Materials and Methods {#s1}
=====================

All chemicals used in this study were purchased from Sigma Aldrich, St Louis, MO, USA, unless otherwise specified. All animal procedures were performed according to the ethics committees for animal care and use, Faculty of Veterinary Science, Chulalongkorn University (Approval no. 12310048).

Oocyte collection
-----------------

Ovaries from routinely ovariohysterectomized mixed-breed domestic cats (*Felis catus*) at various stages of the estrous cycle were collected from the Veterinary Public Health Division of the Bangkok Metropolitan Administration. The ovaries were maintained and transported at room temperature (26--30 C) in 0.9% (wt/vol) normal saline containing 100 IU/ml penicillin and 100 µg/ml streptomycin within 2 h after surgery. The ovaries were washed twice in the same antibiotic-supplemented saline solution and then placed in a holding medium (HM) (HEPES-buffered M199 supplemented with 1 mM sodium pyruvate, 2 mM L-glutamine, 100 IU/ml penicillin and 4 mg/ml bovine serum albumin \[BSA; A3311\]). Cumulus oocyte complexes (COCs) were recovered by cutting the surface of the ovaries using a scalpel blade and assessed for morphology under a stereomicroscope at 40 × magnification (SMZ645; Nikon, Tokyo, Japan). Only oocytes with homogeneous dark cytoplasm and fully surrounded by more than five layers of compacted cumulus cells were selected for IVM.

In vitro maturation and in vitro fertilization
----------------------------------------------

*In vitro* oocyte maturation (IVM) and *in vitro* fertilization (IVF) were performed as described previously \[[@r40]\]. For IVM, groups of 25--40 COCs were cultured in 500 µl of basic IVM medium (NaHCO~3~-M199 with 1.0 mM sodium pyruvate, 2.0 mM L-glutamine, 100 IU/ml penicillin, 50 µg/ml gentamicin, 4 mg/ml BSA) supplemented with 0.05 IU/ml recombinant human follicle-stimulating hormone (rhFSH; Organon, Oss, The Netherlands) and 25 ng/ml EGF. After 22--24 h of IVM, groups of 10 oocytes were transferred to 50 µl droplets of synthetic oviductal fluid (SOF) (containing 6 mg/ml BSA, 100 IU/ml penicillin, 50 µg/ml gentamicin). The frozen semen used in this study was collected from ejaculated sperm of one proven-fertility tom cat. Before IVF, the semen was thawed at 37 C for 30 sec, and only the sperm samples containing more than 50% progressive motility were used. The sperm sample was added to the IVF drop to yield a final concentration of 5×10^5^ sperm/ml. The sperm were co-incubated with the COCs for approximately 18 h at 38.5 C in a humidified atmosphere of 5% CO~2~ in air.

In vitro culture
----------------

Presumptive zygotes (day 0 post IVF) that were surrounded by cumulus cells were washed and cultured in 50 µl droplets of SOF containing with 4 mg/ml BSA, and 100 IU/ml penicillin (IVC-1 medium) for 24 h; after that, all cumulus cells were removed and then assessed for cleavage (*i.e.,* 2--4-cell embryos) on day 2 post IVF (48 h post fertilization). The embryos were transferred to IVC-2 medium (SOF supplemented with the same batch of 10% vol/vol fetal calf serum \[FCS\], JR Scientific, Woodland, CA, USA) and cultured at 38.5 C in a humidified atmosphere of 5% CO~2~ in air for an additional 5 days. Half of the freshly prepared IVC-2 medium was exchanged on day 5 post IVF.

Assessment of embryo development
--------------------------------

The embryos were classified as morulae (having cell compaction without blastocoel formation) on day 5 post IVF, blastocysts (having a fully-expanded blastocoel and two differentiated cell types: inner cell mass and trophectoderm) and hatching blastocysts (hatching of blastocyst cells from zona pellucida) on day 7 post IVF under an inverted microscope at 40 × magnification (CKX41 Olympus, Tokyo, Japan). All blastocysts observed on day 7 were fixed in 4% (wt/vol) paraformaldehyde overnight and washed twice in phosphate buffered saline (PBS) before permeabilization with 0.1% Triton X-100 in PBS for 15 min. Blastocysts were incubated with 1:50 goat anti-OCT3/4 polyclonal IgG antibodies (SC8629, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 37 C for 1 h and then rinsed in PBS and incubated for 2 h with 1:50 FITC labeled donkey anti-goat IgG (SC2024, Santa Cruz Biotechnology). After OCT3/4 staining, blastocysts were incubated with 1:50 mouse anti-Ki67 monoclonal antibodies (IS626, Clone MIB-1, DakoCytomation Denmark A/S, Glostrup, Denmark) at 37 C for 1 h; and then rinsed in PBS and incubated for 1 h with 1:100 TRITC labeled anti-mouse IgG (T5393) to determine the proliferating cells of the blastocyst. Blastocysts were stained with 0.1 µg/ml 4\',6-Diamidino-2-phenylindole (DAPI) in PBS at 25 C for 10 min, and total cell numbers were assessed under an epifluorescent microscope (BX51 Olympus).

RNA extraction
--------------

RNA extraction was performed as previously described \[[@r41]\]. In brief, total RNA was extracted from a group of 20 day 2 embryos (4--8-cell stage), 15 of day 3 embryos (8--16-cell stage), 10 morulae (day 5) and 5 blastocysts (day 7) produced from the same IVF replicate using an Absolutely RNA Nanoprep Kit (Stratagene, San Diego, CA, USA) following the manufacturer's instructions. The purity and quantity of extracted RNA were assessed using a spectrophotometer (NanoDrop ND-2000, Wilmington, DE, USA) and immediately stored at --80 C until further use. Three replicates were performed in each treatment.

Quantitative RT-PCR (qRT-PCR)
-----------------------------

Reverse transcription (RT) was performed using a First-Strand cDNA Synthesis Kit (SuperScript III Kit, Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The product was stored at --20 C until qPCR analysis. The relative expression levels of the target gene (*EGFR*) were normalized to an endogenous control gene, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (*YWHAZ*), that has previously been shown to be stable during cat preimplantation embryo development \[[@r42]\]: forward primer, 5'GAAGAGTCCTACAAAGACAGCACGC 3', and reverse primer, 5' AATTTTCCCCTCCTTCTCCTGC 3'. The amplicon size of *YWHAZ* was 115 bp. The *EGFR* primer was designed from *Felis catusEGFR* mRNA, complete cds (Accession number: HQ185236.1), using a NCBI primer designing tool (Primer3 software V 0.4.0): forward primer, 5' AGATTGCGAAGGGCATGAAC 3', and reverse primer, 5' GGCGTCTTCACCAGGACATT 3'. The amplicon size of *EGFR* was 118 bp. To confirm the amplified *EGFR*, the amplicon was extracted using a Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech, Agoura Hills, CA, USA) and then submitted for sequencing. The sequences subjected to BLAST searches in the NCBI GenBank database to determine the nucleotide identity prior to being used in this study. The *EGFR* primer designed for this study contained 100% nucleotide identity with the *EGFR* mRNA sequence found in *Felis catus EGFR* mRNA complete cds, HQ185236.1. The qPCR was performed using an Applied Biosystems 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) with Luminaris Color HiGreen High ROX qPCR Master Mix (Thermo Scientific, Thermo Fisher Scientific, Carlsbad, CA, USA).

Each PCR reaction (total volume of 10 µl) consisted of 2.5 µl of DNA mixture, which contained 2 µl of reverse transcription product containing either reverse transcriptase (RT+) or not containing reverse transcriptase (RT-) as a control, 0.5 µl of yellow sample buffer and 7.5 µl of a reaction mixture that contained 5 µl of Luminaris Color HiGreen High ROX qPCR Master Mix, 0.3 µl of both 10 µM forward and reverse primers and 1.9 µl of nuclease-free water. The thermal cycling conditions were as follows: 2 min at 50 C for pretreatment of uracil-DNA glycosylase (UDG), 10 min at 95 C to activate Tag DNA polymerase; and 40 cycles of 15 sec at 95 C for denaturing, 30 sec at 55 C for annealing and 60 sec at 72 C for extension. The relative expression was quantified by Sequence Detection System (SDS) Software Version 1.4 (Applied Biosystems). Day 2 embryos were used as a control group for calculations of relative expression performed by the comparative Ct method. Data were reported as the relative fold difference in relation to the control group \[[@r43]\]. qPCR products were confirmed by melting curve analysis and run in gel electrophoresis. The qPCR products were analyzed on a 2% agarose gel (Bio-Rad, Hercules, CA, USA) in 1 × TBE buffer (90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH8) containing 1 ×/ml Redsafe Nucleic Acid Staining Solution (Intron Biotechnology, Gyeonggi-do, Republic of Korea). This was then visualized under UV light (Syngene, Cambridge, UK).

Experimental design
-------------------

Experiment 1: Effect of EGF supplementation on developmental competence of embryos cultured singly compared with group-cultured embryos without growth factor supplementation

This experiment determined the effect of EGF supplementation on developmental competence of singly cultured embryos compared with group-cultured embryos without growth factor supplementation. Single embryos at the cleavage stage (1 embryo/50 µl droplet) were cultured in IVC-2 medium supplemented with different concentrations of EGF (0, 5, 25, 50, and 100 ng/ml) from day 2 to 7. Groups of cleaved embryos (10 embryos/50 µl droplet) cultured in IVC-2 medium without growth factor supplementation from day 2 to 7 served as a control. The embryos were assessed for morula formation on day 5 and blastocyst formation on day 7. Three replicates were performed in this experiment.

Experiment 2: Effect of EGF on developmental competence and expressions of EGFR, OCT3/4 and Ki67 of embryos cultured singly or in groups

Experiment 2.1: Effect of EGF on developmental competence of embryos cultured singly or in groups

The results of experiment 1 showed that EGF supplementation even at the lowest dosage (5 ng/ml) significantly promoted blastocyst formation of singly cultured embryo. This experiment aimed to investigate the effect of EGF (5 ng/ml) supplementation on developmental competence of either singly or group-cultured embryos. Cleavage stage embryos were cultured individually or in groups in IVC-2 medium with or without 5 ng/ml EGF supplementation from day 2 to 7. The control was groups of embryos cultured without EGF supplementation. The embryos were assessed for morula formation on day 5 and blastocyst formation on day 7. Four replicates were performed in this experiment.

Experiment 2.2: Effect of EGF on EGFR expression of embryos cultured singly or in groups

To evaluate the influence of EGF on *EGFR* expression at different developmental stages, day 2 embryos (4--8 cells; D2), day 3 embryos (8--16 cells; D3), morula (D5) and blastocyst (D7) stage embryos produced in experiment 2.1 were subjected to qPCR to assess mRNA expression. The relative expressions of 8--16-cell embryos, morulae and blastocysts were calculated based on the ΔCT of the control (Day 2 embryos). Three replicates were performed in this experiment.

Experiment 2.3: Effect of EGF on OCT3/4 and Ki67 expression in blastocyst from single and group cultures

To determine the expression of OCT3/4 and Ki67 (a proliferative marker), day 7 blastocysts produced in experiment 2.1 were assessed for OCT3/4- and Ki67-positive cells using immunofluorescent staining. The ratios between the numbers of OCT3/4- and Ki67-positive cells to the total number of cells in each blastocyst were proportionally calculated and compared among the different culture conditions. Forty blastocysts per culture treatment were randomly selected and used.

Statistical analysis
--------------------

Results were expressed as the mean ± standard error of the mean (SEM). The percentage of cleavage was calculated relative to the number of oocytes subjected to IVF. Percentages of morulae and day 7 blastocysts were calculated relative to the number of cleaved embryos. Percentage of hatching blastocysts was calculated relative to the total number of blastocysts. Differences between groups in the mean percentage of each developmental stage were assessed by the Chi-squared test. The differences in cell numbers in each group and relative mRNA expression of *EGFR* were assessed by one-way ANOVA, using the general linear model method. The differences in the ratio between numbers of OCT3/4- and Ki67-positive cells to the total number of cells in each blastocyst among culture conditions were assessed by Kruskal-Wallis test. All statistical analyses were performed using the Statistical Analysis Systems software package (Version 9.0, SAS Institute, Cary, NC, USA). Differences with P \< 0.05 were considered statistically significant.

Results {#s2}
=======

Experiment 1: Effect of EGF supplementation on developmental competence of embryos cultured singly compared with group-cultured embryos without growth factor supplementation
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In the absence of EGF, more blastocysts were observed on day 7 in group culture than in the singly cultured group (P \< 0.05, [Table 1](#tbl_001){ref-type="table"}Table 1.Mean percentages (± SEM) of morulae and day 7 blastocysts and numbers of hatching blastocysts and cells in embryo cultured in groups without EGF supplementation and those cultured singly with 0, 5, 25, 50 and 100 ng/ml EGFGroupNo. of cleaved\
embryosNo. of cleaved embryos developed toNo. of hatching\
blastocystsCell numbersMorula (%)Day 7 blastocyst (%)Group w/o EGF6541 (63.1 ± 6.4)36 (55.4 ± 2.9)^a^14 (38.9 ± 7.2)155.3 ± 11.2EGF 0 ng/ml5536 (65.5 ± 5.8)20 (36.4 ± 7.7)^b^5 (25.0 ± 11.4)146.3 ± 9.3EGF 5 ng/ml5737 (64.9 ± 6.4)32 (56.1 ± 6.6)^a^14 (43.8 ± 16.0)186.7 ± 9.1EGF 25 ng/ml6135 (57.4 ± 6.4)26 (42.6 ± 6.4)^a^9 (34.6 ± 10.0)161.4 ± 10.2EGF 50 ng/ml5833 (56.9 ± 6.6)30 (51.7 ± 6.6)^a^13 (43.3 ± 6.2)188.0 ± 12.7EGF 100 ng/ml6645 (68.2 ± 5.8)36 (54.5 ± 6.2)^a^13 (36.1 ± 5.6)166.6 ± 17.1^a,b^ Within a column, different superscripts denote values that differ significantly (P ≤ 0.05). w/o, without.). However, culture conditions did not affect the numbers of morulae and hatching blastocysts produced or the total cell number of blastocysts (P \> 0.05). Addition of EGF, even at the low dosage of 5 ng/ml, enhanced blastocyst production in the single-embryo culture system to a level comparable (P \> 0.05) to group culture ([Table 1](#tbl_001){ref-type="table"}).

Experiment 2: Effect of EGF on developmental competence and the expressions of EGFR, OCT3/4 and Ki67 in embryos cultured singly or in groups
--------------------------------------------------------------------------------------------------------------------------------------------

Experiment 2.1: Effect of EGF on developmental competence of embryos cultured singly or in groups

EGF supplementation did not enhance embryonic development in group culture. However, the percentage of embryos developing to the morula stage was higher in group culture with EGF supplementation than in single-embryo culture (P \< 0.05, [Table 2](#tbl_002){ref-type="table"}Table 2.Mean percentages (± SEM) of morulae and day 7 blastocysts and numbers of hatching blastocysts and cells in embryo cultured in groups and singly without or with 5 ng/ml EGF supplementationGroupNo. of cleaved\
embryosNo. of cleaved embryos developed toNo. of hatching\
blastocystsCell numbersMorula (%)Day 7 blastocyst (%)Group w/o EGF9073 (81.1 ± 4.3)^ab^65 (72.2 ± 3.8)^a^40 (61.5 ± 6.7)157.6 ± 10.2Group + EGF 5 ng/ml9079 (87.8 ± 7.1)^a^58 (64.4 ± 4.1)^a^32 (55.2 ± 5.1)160.4 ± 11.5Single w/o EGF8866 (75.0 ± 5.7)^b^41 (46.6 ± 2.4)^b^24 (58.5 ± 6.1)172.9 ± 12.0Single + EGF 5 ng/ml8663 (73.3 ± 4.2)^b^55 (64.1 ± 8.0)^a^33 (60.0 ± 8.0)160.0 ± 11.0^a,b^ Within a column, different superscripts denote values that differ significantly (P ≤ 0.05). w/o, without.). EGF enhanced blastocyst development in single-embryo culture to a level comparable to group culture ([Table 2](#tbl_002){ref-type="table"}). Culture conditions did not affect the number of hatching blastocysts or blastocyst cell numbers.

Experiment 2.2: Effect of EGF on EGFR expression of embryos cultured singly or in groups

When examining the influence of culture conditions on *EGFR* expression at a given developmental stage, EGF addition as well as culture density (group versus single) did not influence *EGFR* expression of 8--16-cell embryos ([Fig. 1a](#fig_001){ref-type="fig"}Fig. 1.(a) Relative expression (mean ± SEM) of EGFR transcript in 8--16-cell embryos on day 3 cultured either singly or in groups without (D3S, D3G) or with EGF supplementation (D3SE, D3GE). (b) Relative expression (mean ± SEM) of EGFR transcript in morulae on day 5 cultured either singly or in groups without (D5S, D5G) or with EGF supplementation (D5SE, D5GE). (c) Relative expression (mean ± SEM) of EGFR transcript in blastocysts on day 7 cultured either singly or in groups without (D7S, D7G) or with EGF supplementation (D7SE, D7GE). Relative expression analyzed using real-time PCR with YWHAZ used to normalize each gene, and 4--8-cell embryos (D2) used as calibrators. ^a,b^ Different letters on bars indicate values that differ significantly (P \< 0.05).). However, *EGFR* transcripts were significantly higher in morula stage embryos cultured singly in the absence of EGF than in morula stage embryos under other culture conditions (P \< 0.05; [Fig. 1b](#fig_001){ref-type="fig"}). In blastocysts, EGF significantly decreased *EGFR* expression in those cultured singly or in groups ([Fig. 1c](#fig_001){ref-type="fig"}).

Experiment 2.3: The effect of EGF on the ratio of OCT3/4- and Ki67-expressing cells in blastocysts from single and group cultures

Culture conditions did not influence the ratio of OCT3/4-positive cells to the blastocyst total cell numbers under both the single-embryo and group culture conditions. However, EGF increased the ratio of Ki67-positive cells to the blastocyst total cell numbers under the single-embryo culture conditions compared with group culture cohorts ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Ratios of OCT3/4- and Ki67-positive cells to total cell number (TCN) among blastocysts derived from embryos cultured singly and in groups without (CS or CG respectively) or with 5 ng/ml EGF supplementation (SE or GE, respectively). ^a,b^ Different letters on bars indicate values that differ significantly (P \< 0.05).; P \< 0.05). Immunofluorescent staining showed the presence of OCT3/4 protein in nuclei of both ICM and trophectoderm cells with a prominence observed in the ICM ([Fig. 3a](#fig_003){ref-type="fig"}Fig. 3.Immunofluorescent staining of blastocysts for OCT3/4 (a) and Ki67 (b). DAPI staining to show blastomere nuclei (c). Bar = 50 µm.). Ki67 protein expression was also detected in the nucleolus of both ICM and trophectoderm cells ([Fig. 3b](#fig_003){ref-type="fig"}).

Discussion {#s3}
==========

Culturing a single embryo in a large volume droplet has been shown to impede embryonic development in many mammalian species, including the mouse, cow and cat \[[@r13], [@r41], [@r44],[@r45],[@r46],[@r47]\]. However, growth factor supplementation can circumvent the adverse effects of low-density embryo culture and thus, enhance embryonic development *in vitro* \[[@r13], [@r48]\]. The present study demonstrates (1) that addition of EGF to a culture medium enhanced the ability of singly cultured embryos to form blastocysts, likely by promoting cell proliferation, and (2) that the *EGFR* expression level at various developmental stages was influenced by culture density and growth factor supplementation.

During preimplantation development, mammalian embryos undergo cell proliferation, differentiation and apoptosis, all of which are regulated by growth factors secreted from the maternal reproductive tract or embryos themselves \[[@r49]\]. The absence of growth factors or disruption of paracrine/autocrine signaling often results in growth retardation, chromosomal abnormalities, alteration of gene expression, metabolic disruption and increased apoptosis levels \[[@r50], [@r51]\]. Growth factors exert their effects on preimplantation embryo development by binding to their receptor located within the reproductive tract or an embryo's plasma membrane, which, in turn, stimulates downstream signaling pathways regulating cell proliferation and differentiation \[[@r18]\]. To date, the members of the insulin and insulin-like growth factor (IGF) family, epidermal growth factor (EGF) family, platelet-derived growth factor (PDGF) family and tumor necrosis factor (TNF) family have been shown to regulate embryo development in the cat, mouse, cow, rat, human, pig, sheep and rabbit \[[@r20], [@r49], [@r52]\]. EGF has been shown to be involved in blastocyst formation via stimulating protein synthesis, especially in trophectoderm cells \[[@r49], [@r52]\].

Our finding that group embryo culture yielded more blastocysts than single-embryo culture is consistent with previous studies in the cat \[[@r9]\], mouse \[[@r2]\], cow \[[@r53]\] and human \[[@r54]\]. Previous studies have shown that embryo density significantly affects *in vitro* embryonic development in the cat and others species \[[@r15], [@r41], [@r55], [@r56]\]. Specifically, a high embryo density (10 embryos: 12.5 µl medium volume; 1:1.25) often results in fragmentation of cell nuclei and a low blastocyst formation rate due to upregulation of genes regulating stress response (HSP70) or apoptosis (BAX) \[[@r56], [@r57]\], while a low embryo density (1 embryo, 20--50 µl medium volume) compromises blastocyst formation and reduces the blastocyst cell number \[[@r13], [@r17]\].

Generally, optimal embryonic development can be obtained when the embryo density is one embryo per 5--10 µl \[[@r57], [@r58]\]. Culturing single human embryos in small droplets (individual culture in 20 µl droplets or in ultramicrodroplets \[1.5 to 2 µl\]) yielded a higher number of blastomeres, and the implantation or even pregnancy rate were comparable to those of embryos cultured in 50 µl droplets \[[@r2]\]. It has been postulated that an increased embryo density improves blastocyst development by facilitating localization of growth factors, nutrients and beneficial metabolites while limiting diffusion of these embryotrophic substances away from the embryos \[[@r59]\]. Future studies on the effect of culturing individual embryos in droplets with a small volume on cat embryonic development are warranted.

Several studies have demonstrated that growth factors enhance blastocyst formation in the group cultured system by decreasing the rate of apoptosis and enhancing cell proliferation and protein synthesis \[[@r19], [@r32], [@r60], [@r61]\]. Specifically, supplementation of EGF at 5 ng/ml from 18 h post insemination to 192 h post insemination increased the percentage of bovine blastocysts in group culture (20 embryos/50 µl) compared with an unsupplemented group \[[@r32]\]. In contrast, our study found that supplementation of EGF in the group cultured system did not promote blastocyst formation. This discrepancy may be due to a species-specific response to EGF (cat versus cow) or the differences in embryo density (10 embryos in 50 µl versus 20 embryos in 50 µl) between the two studies.

It has been suggested that when embryos are cultured individually, most embryo-derived autocrine growth factors are diluted in this system \[[@r13], [@r19]\]. Growth factor supplementation could at least compensate for the low concentration of growth factors under these culture conditions \[[@r13], [@r19]\]. EGF was considered one of the autocrine growth factors produced from human preimplantation embryos at the 8-cell and blastocyst stage \[[@r62]\]. Our study found that addition of EGF even at a low concentration (5 ng/ml) enhanced blastocyst development to the same level as the group culture control. It should be noted that fetal bovine serum was present in the culture medium used in this study. The addition of serum to the culture medium was due to the limited ability of simple media to support embryo development in the absence of serum \[[@r63]\]. While it is known that serum contains several unknown factors that can promote or inhibit embryonic development \[[@r63]\], this protein supplement was added to all culture treatments, including the no EGF control. Thus, the increased blastocyst development in the embryos cultured singly in the presence of EGF was likely due to the beneficial effect of this growth factor.

This study also found that *EGFR* was expressed throughout the cat preimplantation developmental stages (4--8-cell embryos, 8--16-cell embryos, morulae and blastocysts) under both the group and single-embryo culture conditions. The influence of EGF on *EGFR* expression was assessed and found to decrease the expression of *EGFR* transcript in morulae cultured singly and blastocysts cultured either individually or in groups. This finding is contrary to that of a previous study in which EGF supplementation at 0.1 ng/ml significantly increased *EGFR* expression in preimplantation mouse embryos compared with the control and groups treated with higher concentrations of EGF (1, 10 and 100 ng/ml). Furthermore, in that study, *EGFR* expression tended to decrease as the EGF dosage increased \[[@r64]\]. Therefore, the inconsistency between our study and the previous finding may be due to the different concentrations of EGF (0.1 ng/ml *vs*. 25 ng/ml) or species differences. It has been previously shown in a pleochromocytoma of the rat adrenal medulla cell line (PC12 cells) and human squamous carcinoma cell line (A431) that after binding to its ligand and internalization, EGFR either recycles back to the cell surface or is transported to endosomes/lysosomes for degradation \[[@r65], [@r66]\]. Addition of EGF to a culture medium may result in excessive binding of EGFR and its ligand that leads to the reduction of EGFR on the cell surface. Nevertheless, the downregulation of *EGFR* observed in the present study did not result in decreased embryonic development, as EGF increased morula development in group culture and blastocyst formation in embryos cultured singly. To date, the exact mechanisms by which EGF stimulates blastocyst formation of embryos cultured singly have not been determined. Our study found that EGF supplementation significantly increased the proportion of Ki67-positive cells within blastocysts derived from individual embryo culture, although the total cell numbers proportions of OCT3/4-positive cells did not differ. This suggests that the EGF supplementation exerted a positive effect on the proliferative activity of the blastocysts, as Ki67 is considered a marker of cell proliferation in only active stages of the cell cycle (G1, S, G2 and M) in mouse embryos \[[@r36], [@r37]\]. Previous studies demonstrated that EGF stimulated entry of rat hepatocytes into the S phase \[[@r67]\] and the proliferative fraction (S and G2/M phase) in a normal human breast epithelial cell line (MCF10A) \[[@r68]\]. However, the progression of the cell cycle from the G2 to M phase required the activation of EGFR \[[@r68], [@r69]\], but we did not find upregulation of EGFR in blastocysts. Thus, the beneficial effect of EGF on singly cultured cat embryos observed in the present study is likely, in part, due to the progression of the cell cycle (from the G1 to G2 phase). Future studies that involve incubating cat embryos with EGF and specific inhibitors of *EGFR* or MAPK will confirm this hypothesis.

In conclusion, these research findings demonstrated that EGF plays an important role in cat embryo development. Furthermore, the findings show that EGF-enhanced development of domestic cat embryos cultured singly can be extrapolated to improve the developmental potential of wild felid embryos, especially when the numbers of high-quality oocytes are limited.

C Thongkittidilok is the recipient of a grant from the Royal Golden Jubilee Ph.D. Program (PHD0032/2553), Thailand Research Fund (TRF). This research was financially supported by the 90^th^ Anniversary of Chulalongkorn University Fund and TRF-RSA5680028. Finally, the authors would like to thank the Veterinary Public Health Division of the Bangkok Metropolitan Administration, Thailand, for sample collection.
